Education
About Us
Working with TipRanks
Follow Us
Biodesix (BDSX)
NASDAQ:BDSX
Earnings Data
Report Date
Oct 31, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.07Last Year’s EPS
-0.07Same Quarter Last Year
Moderate Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call reflects positive developments in revenue growth, particularly in lung diagnostic testing and development services, as well as in operational efficiency with improved gross margins. However, these positives are offset by increased operating expenses, net loss, and adjusted EBITDA loss, which paint a balanced picture of achievements and challenges.Company Guidance
Revenue Growth
Biodesix reported a 12% increase in total revenue year-over-year, achieving $20 million in the second quarter of 2025.
Lung Diagnostic Testing Expansion
The company increased lung diagnostic testing revenue by 8% and test volumes by 9%, with $17.9 million in revenue from approximately 15,100 tests.
Development Services Growth
Development Services revenue grew 53% year-over-year to $2.1 million, with $12.5 million under contract, representing a 54% increase over the prior year and an all-time high.
Improved Gross Margins
Gross margins improved by 150 basis points to 80%, despite increases in supply costs and macroeconomic uncertainty.
Primary Care Strategy Success
Primary care ordering of lung diagnostic tests increased to 9% in June, up from 4% prior to the pilot program in 2024.
BDSX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BDSX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 07, 2025 | $0.45 | $0.40 | -11.11% |
May 13, 2025 | $0.36 | $0.22 | -38.89% |
Mar 03, 2025 | $0.71 | $0.72 | +1.41% |
Nov 01, 2024 | $1.70 | $1.30 | -23.53% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Biodesix (BDSX) report earnings?
Biodesix (BDSX) is schdueled to report earning on Oct 31, 2025, After Close (Confirmed).
What is Biodesix (BDSX) earnings time?
Biodesix (BDSX) earnings time is at Oct 31, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BDSX EPS forecast?
BDSX EPS forecast for the fiscal quarter 2025 (Q3) is -0.07.